Cannabis Stocks Rally Hard as Sector Eyes Best Weekly Gains of 2026

Cannabis stocks are experiencing their strongest weekly rally in over two years, with major operators and MSOs posting double-digit gains as institutional money flows back into the sector. The broad-based surge marks a dramatic reversal from the prolonged bear market that has plagued cannabis equities since their 2021 peaks.

The rally spans across all major cannabis subsectors, from multi-state operators like Curaleaf and Trulieve to Canadian licensed producers including Canopy Growth and Tilray. Trading volumes have spiked 300% above recent averages as both retail and institutional investors chase momentum in names that have been beaten down for years.

Several catalysts are driving the renewed interest in cannabis stocks. Federal rescheduling discussions have gained fresh momentum following recent DEA comments, while state-level expansion continues with new adult-use markets coming online. The sector's improved fundamentals also play a role - many operators now generate positive EBITDA and have strengthened balance sheets through debt restructuring.

Technical factors amplify the move as heavily shorted cannabis names face squeeze pressure. Short interest across the sector remains elevated despite recent covering, creating potential for additional upside if momentum continues. Options activity has also surged, with call volume outpacing puts by the widest margin in 18 months.

The sustainability of this rally depends on whether institutional investors view current levels as attractive entry points or temporary oversold bounces. Cannabis stocks remain down 70-80% from their 2021 highs despite recent gains, suggesting either significant value or continued fundamental challenges. Upcoming quarterly earnings from major operators will provide crucial data points for whether operational improvements can justify renewed investor optimism.